PERT medicine supply disruption

NHS Cheshire and Merseyside has worked with our partners across the region to provide patient information to manage the current shortages of pancreatic replacement therapy (PERT) often known as Creon, Pancrex or other brands.

The guidance below is intended to support patients through the current shortage which we expect will last until at least 2026.